Citadel Advisors’s Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant IBER.U Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-227,788	Closed	-$2.29M	–	7388
2021 Q2	$2.29M	Sell	227,788 -547,212	-71%	-$5.5M	﹤0.01%	3054
2021 Q1	$7.64M	Buy	+775,000	New	+$7.64M	﹤0.01%	1667